-The Hindu   The Supreme Court's reasoning in the Devinder Pal Singh Bhullar case reveals an unfortunate determination to sanction judicial execution because it involved a terrorist offence. If there is one principle that emerges from the judgment of Justice G.S. Singhvi and Justice S.J. Mukhopadhaya, it is that prolonged delay in disposal of a mercy petition, until now considered a possible constitutional limitation on carrying out an execution, will not be...

KEY TRENDS   • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8   • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...

-The Times of India SURAT: If Manjuben Chaudhary of Dinbari village does not wake up at 3.30am, she will have to walk at least five km in scorching sun to fetch water. She has to reach the village well by 4am sharp or else her turn to fill water would come after four hours. Reeling under severe scarcity, this tribal hamlet in Valsad's Kaprada taluka has been forced to chalk...

-The Hindu Imphal: The Manipur Women's Commission has said it is imperative to hold an in-depth police investigation into the April 3 murder of Satyabhama Ningombam. Talking to journalists here, Chairperson Ibetombi Irengbam said the police should interact with the bereaved family, local residents and employees of the Pathology department of the Regional Institute of Medical Sciences here, where Sayabhama was a research fellow. The post-mortem report should be properly studied and if...

-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...